These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21750169)

  • 21. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.
    Del Vecchio Blanco G; Cretella M; Paoluzi OA; Caruso A; Mannisi E; Servadei F; Romeo S; Grasso E; Sileri P; Giannelli M; Biancone L; Palmieri G; Pallone F
    Colorectal Dis; 2013 Sep; 15(9):1093-9. PubMed ID: 23627814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative colonoscopy for patients with gastric adenocarcinoma.
    Kim HO; Hwang SI; Yoo CH; Kim H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1740-4. PubMed ID: 19686412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.
    Yang MH; Son HJ; Lee JH; Kim MH; Kim JY; Kim YH; Chang DK; Rhee PL; Kim JJ; Rhee JC
    Gastrointest Endosc; 2010 Apr; 71(4):774-81. PubMed ID: 20363417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
    de Jong AE; Morreau H; Nagengast FM; Mathus-Vliegen EM; Kleibeuker JH; Griffioen G; Cats A; Vasen HF
    Am J Gastroenterol; 2005 Jan; 100(1):139-43. PubMed ID: 15654793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
    Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
    Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
    BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenium, apoptosis, and colorectal adenomas.
    Connelly-Frost A; Poole C; Satia JA; Kupper LL; Millikan RC; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):486-93. PubMed ID: 16537706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of colorectal neoplasia in patients with gastric cancer: a Korean Association for the Study of Intestinal Disease (KASID) Study.
    Park DI; Park SH; Yoo TW; Kim HS; Yang SK; Byeon JS; Koh BM; Kim JO; Shim KN; Jeen YT; Lee BI; Choi KY; Lee HL; Han DS; Baek I; Park CH; Park SJ
    J Clin Gastroenterol; 2010 Feb; 44(2):102-5. PubMed ID: 19561531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer.
    Hoffmeister M; Schmitz S; Karmrodt E; Stegmaier C; Haug U; Arndt V; Brenner H
    Clin Gastroenterol Hepatol; 2010 Oct; 8(10):870-6. PubMed ID: 20670694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening colonoscopy among persons 50 to 60 years of age with and without familial risk of colorectal cancer - a prospective multicenter trial].
    Sieg A; Für Die BNG-Studiengruppe
    Z Gastroenterol; 2003 Nov; 41(11):1077-82. PubMed ID: 14648376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
    Chung SJ; Kim YS; Yang SY; Song JH; Kim D; Park MJ; Kim SG; Song IS; Kim JS
    Gut; 2011 Nov; 60(11):1537-43. PubMed ID: 21427200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.